These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 29235884

  • 1. Cost per successfully treated patient for vortioxetine versus duloxetine in adults with major depressive disorder: an analysis of the complete symptoms of depression and functional outcome.
    Christensen MC, Munro V.
    Curr Med Res Opin; 2018 Apr; 34(4):593-600. PubMed ID: 29235884
    [Abstract] [Full Text] [Related]

  • 2. Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: A novel dual outcome measure in depressive disorders.
    Christensen MC, Loft H, McIntyre RS.
    J Affect Disord; 2018 Feb; 227():787-794. PubMed ID: 29689693
    [Abstract] [Full Text] [Related]

  • 3. Successfully treated patients with vortioxetine versus venlafaxine: a simplified cost-effectiveness analysis based on a head-to-head study in Asian patients with major depressive disorder.
    Wang G, Zhao K, Reynaud-Mougin C, Loft H, Ren H, Eriksen HF, Ettrup A.
    Curr Med Res Opin; 2020 May; 36(5):875-882. PubMed ID: 31990207
    [Abstract] [Full Text] [Related]

  • 4. Effects of vortioxetine on functional capacity across different levels of functional impairment in patients with major depressive disorder: a University of California, San Diego Performance-based Skills Assessment (UPSA) analysis.
    Jacobson W, Zhong W, Nomikos GG, Christensen MC, Kurre Olsen C, Harvey PD.
    Curr Med Res Opin; 2020 Jan; 36(1):117-124. PubMed ID: 31422713
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cognitive improvement in late-life depression treated with vortioxetine and duloxetine in an eight-week randomized controlled trial: The role of age at first onset and change in depressive symptoms.
    Xue L, Bocharova M, Young AH, Aarsland D.
    J Affect Disord; 2024 Sep 15; 361():74-81. PubMed ID: 38838790
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L.
    J Affect Disord; 2016 May 15; 196():225-33. PubMed ID: 26938965
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effects of vortioxetine on cognitive performance in working patients with major depressive disorder: A short-term, randomized, double-blind, exploratory study.
    Baune BT, Sluth LB, Olsen CK.
    J Affect Disord; 2018 Mar 15; 229():421-428. PubMed ID: 29331703
    [Abstract] [Full Text] [Related]

  • 12. A Subgroup Analysis of the Impact of Vortioxetine on Functional Capacity, as Measured by UPSA, in Patients with Major Depressive Disorder and Subjective Cognitive Dysfunction.
    Keefe RSE, Nomikos G, Zhong W, Christensen MC, Jacobson W.
    Int J Neuropsychopharmacol; 2018 May 01; 21(5):442-447. PubMed ID: 29546401
    [Abstract] [Full Text] [Related]

  • 13. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Khan A, Bose A, Alexopoulos GS, Gommoll C, Li D, Gandhi C.
    Clin Drug Investig; 2007 May 01; 27(7):481-92. PubMed ID: 17563128
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.
    Lewis-Fernández R, Lam P, Lucak S, Galfalvy H, Jackson E, Fried J, Rosario M, de la Cruz AA, Sánchez-Lacay A, Díaz S, Schneier F.
    J Clin Psychopharmacol; 2016 Dec 01; 36(6):710-715. PubMed ID: 27755218
    [Abstract] [Full Text] [Related]

  • 18. Validation of the University of California San Diego Performance-based Skills Assessment (UPSA) in major depressive disorder: Replication and extension of initial findings.
    Christensen MC, Sluth LB, McIntyre RS.
    J Affect Disord; 2019 Feb 15; 245():508-516. PubMed ID: 30439678
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.